Hepcidin: an important new regulator of iron homeostasis

被引：46
作者：
Hugman, A [1 ]
机构：
[1] Royal Prince Alfred Hosp, Inst Haematol, Sydney, NSW, Australia
来源：
CLINICAL AND LABORATORY HAEMATOLOGY | 2006年 / 28卷 / 02期
关键词：
hepcidin; iron; iron metabolism; anaemia; iron overload;
D O I：
10.1111/j.1365-2257.2006.00768.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepcidin is an important and recently discovered regulator of iron homeostasis. There is strong evidence in support of an important role for hepcidin dysregulation in the pathogenesis of iron overload disorders, and possibly in the aetiology of the anaemia of chronic disease. Further research is needed into the physiology of hepcidin to elucidate the relative contributions of the liver and kidney to its production and metabolism. The study of the differential roles of prohepcidin and its metabolites as well as the significance of their serum and urine levels will enhance our understanding of their role in iron metabolism.
引用
收藏
页码：75 / 83
页数：9
相关论文
共 44 条
  • [1] Decreased hepcidin mRNA expression in thalassemic mice
    Adamsky, K
    Weizer, O
    Amariglio, N
    Breda, L
    Harmelin, A
    Rivella, S
    Rachmilewitz, E
    Rechavi, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) : 123 - 124
  • [2] Decreased liver hepcidin expression in the Hfe knockout mouse
    Ahmad, KA
    Ahmann, JR
    Migas, MC
    Waheed, A
    Britton, RS
    Bacon, BR
    Sly, WS
    Fleming, RE
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) : 361 - 366
  • [3] Molecular control of iron metabolism
    Andrews, NC
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) : 159 - 169
  • [4] Aoki CA, 2005, J CLIN GASTROENTEROL, V39, P71
  • [5] Serum hepcidin in clinical specimens
    Dallalio, G
    Fleury, T
    Means, RT
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (06) : 996 - 1000
  • [6] Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function
    Dètivaud, L
    Nemeth, E
    Boudjema, K
    Turlin, B
    Troadec, MB
    Leroyer, P
    Ropert, M
    Jacquelinet, S
    Courselaud, B
    Ganz, T
    Brissot, P
    Loréal, O
    [J]. BLOOD, 2005, 106 (02) : 746 - 748
  • [7] Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin
    Drakesmith, H
    Schimanski, LM
    Ormerod, E
    Merryweather-Clarke, AT
    Viprakasit, V
    Edwards, JP
    Sweetland, E
    Bastin, JM
    Cowley, D
    Chinthammitr, Y
    Robson, KJH
    Townsend, ARM
    [J]. BLOOD, 2005, 106 (03) : 1092 - 1097
  • [8] A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
    Feder, JN
    Gnirke, A
    Thomas, W
    Tsuchihashi, Z
    Ruddy, DA
    Basava, A
    Dormishian, F
    Domingo, R
    Ellis, MC
    Fullan, A
    Hinton, LM
    Jones, NL
    Kimmel, BE
    Kronmal, GS
    Lauer, P
    Lee, VK
    Loeb, DB
    Mapa, FA
    McClelland, E
    Meyer, NC
    Mintier, GA
    Moeller, N
    Moore, T
    Morikang, E
    Prass, CE
    Quintana, L
    Starnes, SM
    Schatzman, RC
    Brunke, KJ
    Drayna, DT
    Risch, NJ
    Bacon, BR
    Wolff, RK
    [J]. NATURE GENETICS, 1996, 13 (04) : 399 - 408
  • [9] Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease
    Fleming, RE
    Sly, WS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) : 8160 - 8162
  • [10] Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    Ganz, T
    [J]. BLOOD, 2003, 102 (03) : 783 - 788
12345